Le Lézard
Classified in: Health, Science and technology
Subjects: TRI, FDA

AstaPure® Astaxanthin Approved by Anvisa Brazil

KIBBUTZ KETURA, Israel, July 26, 2017 /PRNewswire/ --

Algatech (Algatechnologies) Ltd. Received Brazilian Health Regulatory Agency (Anvisa) approval for its all-natural astaxanthin AstaPure® to be used as a food ingredient. Approval was granted thanks to the high quality and purity of this powerful product.

     (Photo: http://mma.prnewswire.com/media/539278/AstaPure_Astaxanthin.jpg )

This approval makes Algatech the first astaxanthin supplier to start marketing its clean-label astaxanthin under the AstaPure brand in Brazil. AstaPure is sourced from the Haematococcus pluvialis microalgae, cultivated in a proprietary fully controlled closed system of glass photo-bioreactors energized by the abundant natural sunlight of the Arava desert.

Brazil has the largest nutritional and supplements market in South America. According to Euromonitor, vitamins and dietary supplements recorded a sales total of US$1.3 billion in 2015 in Brazil, an 11% increase over the previous year. The market shows no signs of slowing down, due to a growing and increasingly health conscious middle-class. Brazil is poised to take the next step in becoming a global powerhouse with exciting potential.

"Brazil holds the leading supplement market in South America, and we strongly believe this approval will create further possibilities in the region," says Gary Brenner, project development manager for Algatech. "Collaborating with our distributor Ayalla, Sao Paulo, we aim to increase our sales and promote our products in cooperation with the leading brand customers in the food, cosmetics and dietary supplements segments."

"Ayalla prides itself in marketing only the highest quality natural nutrients to our Brazilian customers," notes Sandra Ayala de Anselmo, president of marketing for Ayalla. "For two generations, our family has maintained a strong commitment to these standards. Many of our strategic customers already know AstaPure astaxanthin, and we are excited to now realize our investment with the help of Algatech."

"Microalgae is expected to be one of the most important nutrition source of the 21th century. We are proud to be among just a few companies internationally that have cracked the code for commercial-scale production of natural microalgae, at the highest standards," says Hagai Stadler, CEO of Algatech. "We are pleased to bring the Algatech product line to Brazil, and to be able to provide for the first time in Brazil all-natural astaxanthin AstaPure."

Algatech is a leading manufacturer and supplier of innovative algae-based products cultivated using state-of-the-art technologies. The company is located in Israel's Arava desert, between the Dead Sea and the Red Sea, an optimal location for microalgae cultivation, thanks to the stable climate conditions, clean air and water, and intense sunlight throughout the year.

For further information, please contact:

Company contacts
Algatechnologies Ltd.
Ms. Efrat Kat VP, Marketing & Sales
Phone: +972-8-6356425
E-mail: info@algatech.com
Twitter: @Algatech98

Media contact
Ms. Liat Simha
Tel: +972-9-9742893
E-mail: liat@nutripr.com
Website: http://www.NutriPR.com
Twitter: @LiatSimha

SOURCE Algatech Ltd.

These press releases may also interest you

at 01:15
SANTA ROSA, Calif., Oct. 17, 2017 /PRNewswire/ -- Sutter Santa Rosa Regional Hospital announced today that it will reopen with full services at 7 a.m. on Tuesday, Oct. 17? just eight days after the hospital was evacuated during the devastating Tubbs...

16 oct 2017
COLUMBUS, Ga., Oct. 16, 2017 /PRNewswire/ -- Aflac Incorporated announced today that it has priced ¥60 billion (par value) in yen-denominated subordinated debentures with a coupon of 2.108%. The subordinated debentures will mature in 2047 and are...

16 oct 2017
LAVAL, Quebec, Oct. 16, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant") announced today the results to date of the pending cash tender offers (the "Tender Offers") by Valeant and Valeant...

16 oct 2017
NEW YORK, Oct. 16, 2017 /PRNewswire-USNewswire/ -- Two renowned Parkinson's disease and movement disorders physician-researchers have been appointed co-executive directors of the Marlene and Paolo Fresco Institute for Parkinson's and Movement...

16 oct 2017
HERTFORDSHIRE, England, and PITTSBURGH, Oct. 16, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that the United States District Court for the Eastern District of Texas has issued a 135-page decision finding all asserted claims of...

16 oct 2017
LOS ANGELES, Oct. 16, 2017 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that Nasdaq has granted the Company's request for a continued listing pending...

News published on 26 july 2017 at 07:00 and distributed by: